ATE324373T1 - Immunmodulierende verbindungen - Google Patents
Immunmodulierende verbindungenInfo
- Publication number
- ATE324373T1 ATE324373T1 AT02746260T AT02746260T ATE324373T1 AT E324373 T1 ATE324373 T1 AT E324373T1 AT 02746260 T AT02746260 T AT 02746260T AT 02746260 T AT02746260 T AT 02746260T AT E324373 T1 ATE324373 T1 AT E324373T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- relates
- present
- novel heterocyclic
- immunomodulating compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102404A SE0102404D0 (sv) | 2001-07-04 | 2001-07-04 | Novel immunomodulating compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE324373T1 true ATE324373T1 (de) | 2006-05-15 |
Family
ID=20284743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02746260T ATE324373T1 (de) | 2001-07-04 | 2002-07-02 | Immunmodulierende verbindungen |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1409485B1 (de) |
JP (1) | JP2005501033A (de) |
CN (1) | CN1249063C (de) |
AT (1) | ATE324373T1 (de) |
AU (1) | AU2002315996B2 (de) |
BR (1) | BR0210776A (de) |
CA (1) | CA2451749A1 (de) |
DE (1) | DE60210977T2 (de) |
ES (1) | ES2258150T3 (de) |
HK (1) | HK1066809A1 (de) |
HR (1) | HRP20031055B1 (de) |
HU (1) | HUP0401204A3 (de) |
MX (1) | MXPA04000017A (de) |
NO (1) | NO20035684L (de) |
NZ (1) | NZ530316A (de) |
PL (1) | PL367637A1 (de) |
RU (1) | RU2004103079A (de) |
SE (1) | SE0102404D0 (de) |
WO (1) | WO2003004495A1 (de) |
YU (1) | YU101603A (de) |
ZA (1) | ZA200309806B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1562944B1 (de) * | 2002-11-22 | 2007-02-14 | Active Biotech AB | Pyrazolochinoline mit immunmodulierenderwirkung |
ATE425164T1 (de) | 2002-12-16 | 2009-03-15 | Active Biotech Ab | Tetrazyklische immunmodulierende verbindungen |
GB0305876D0 (en) * | 2003-03-14 | 2003-04-16 | Avidex Ltd | Immuno inhibitory heterocyclic compounds |
EP2284172A1 (de) * | 2003-03-14 | 2011-02-16 | MediGene Ltd. | Immunmodulierende heterocyclische Verbindungen |
GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
CA2553329A1 (en) | 2004-01-14 | 2005-07-28 | Ajinomoto Co., Inc. | New fused polycyclic compounds |
GB0411770D0 (en) * | 2004-05-26 | 2004-06-30 | Avidex Ltd | Immuno inhibitory heterocyclic compouds |
DK1776366T3 (da) | 2004-08-09 | 2009-02-16 | Medigene Ltd | Immunomodulerende oxopyrazolocinnoliner som CD80-inhibitorer |
CN101863903B (zh) * | 2010-06-08 | 2014-03-12 | 沈阳药科大学 | 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用 |
BR112015030387B1 (pt) * | 2013-06-24 | 2021-02-09 | Merck Patent Gmbh | compostos de pirazol moduladores de fshr, seus usos, e composição farmacêutica |
EP2883883A1 (de) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden |
NZ728298A (en) | 2014-07-08 | 2017-09-29 | Avertana Ltd | Extraction of products from titanium-bearing minerals |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4268516A (en) * | 1978-10-11 | 1981-05-19 | Pfizer Inc. | [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents |
US4312870A (en) * | 1979-06-21 | 1982-01-26 | Ciba-Geigy Corporation | Pyrazoloquinolines |
GB8818895D0 (en) * | 1988-08-09 | 1988-09-14 | Boots Co Plc | Therapeutic agents |
PH26314A (en) * | 1988-08-09 | 1994-04-29 | Boots Co Plc | Benzopyrano [4,3-c] pyrazoles derivatives |
SE8903564D0 (sv) * | 1989-10-26 | 1989-10-26 | Pharmacia Ab | New use condensed quinoline compound |
BR9105984A (pt) * | 1990-02-02 | 1992-11-10 | Boots Co Plc | Processo de preparacao de derivados do pirazol e de composicoes farmaceuticas que contem os mesmos |
AR006520A1 (es) * | 1996-03-20 | 1999-09-08 | Astra Pharma Prod | Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion. |
-
2001
- 2001-07-04 SE SE0102404A patent/SE0102404D0/xx unknown
-
2002
- 2002-07-02 JP JP2003510662A patent/JP2005501033A/ja not_active Withdrawn
- 2002-07-02 DE DE60210977T patent/DE60210977T2/de not_active Expired - Lifetime
- 2002-07-02 YU YU101603A patent/YU101603A/sh unknown
- 2002-07-02 CN CNB028132890A patent/CN1249063C/zh not_active Expired - Fee Related
- 2002-07-02 AT AT02746260T patent/ATE324373T1/de not_active IP Right Cessation
- 2002-07-02 CA CA002451749A patent/CA2451749A1/en not_active Abandoned
- 2002-07-02 MX MXPA04000017A patent/MXPA04000017A/es active IP Right Grant
- 2002-07-02 RU RU2004103079/04A patent/RU2004103079A/ru not_active Application Discontinuation
- 2002-07-02 NZ NZ530316A patent/NZ530316A/en unknown
- 2002-07-02 EP EP02746260A patent/EP1409485B1/de not_active Expired - Lifetime
- 2002-07-02 BR BR0210776-7A patent/BR0210776A/pt not_active IP Right Cessation
- 2002-07-02 ES ES02746260T patent/ES2258150T3/es not_active Expired - Lifetime
- 2002-07-02 PL PL02367637A patent/PL367637A1/xx not_active Application Discontinuation
- 2002-07-02 HU HU0401204A patent/HUP0401204A3/hu unknown
- 2002-07-02 AU AU2002315996A patent/AU2002315996B2/en not_active Ceased
- 2002-07-02 WO PCT/SE2002/001309 patent/WO2003004495A1/en active IP Right Grant
-
2003
- 2003-12-17 HR HR20031055A patent/HRP20031055B1/xx not_active IP Right Cessation
- 2003-12-19 NO NO20035684A patent/NO20035684L/no not_active Application Discontinuation
- 2003-12-19 ZA ZA200309806A patent/ZA200309806B/en unknown
-
2004
- 2004-12-14 HK HK04109875A patent/HK1066809A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1066809A1 (en) | 2005-04-01 |
DE60210977T2 (de) | 2006-09-21 |
NO20035684L (no) | 2004-03-02 |
NO20035684D0 (no) | 2003-12-19 |
EP1409485A1 (de) | 2004-04-21 |
CN1249063C (zh) | 2006-04-05 |
JP2005501033A (ja) | 2005-01-13 |
MXPA04000017A (es) | 2004-05-21 |
EP1409485B1 (de) | 2006-04-26 |
YU101603A (en) | 2006-05-25 |
ES2258150T3 (es) | 2006-08-16 |
WO2003004495A1 (en) | 2003-01-16 |
HUP0401204A2 (hu) | 2004-10-28 |
ZA200309806B (en) | 2004-12-20 |
BR0210776A (pt) | 2004-07-20 |
NZ530316A (en) | 2004-08-27 |
AU2002315996B2 (en) | 2007-11-29 |
DE60210977D1 (de) | 2006-06-01 |
HRP20031055B1 (en) | 2008-01-31 |
CN1522254A (zh) | 2004-08-18 |
HUP0401204A3 (en) | 2008-03-28 |
CA2451749A1 (en) | 2003-01-16 |
HRP20031055A2 (en) | 2004-06-30 |
PL367637A1 (en) | 2005-03-07 |
SE0102404D0 (sv) | 2001-07-04 |
RU2004103079A (ru) | 2005-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1086562A1 (en) | Pyrazoloquinolines with immunomodulating activity | |
HK1067120A1 (en) | Glutaminyl based dpiv inhibitors | |
WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
MX2021001433A (es) | Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa. | |
ATE324373T1 (de) | Immunmodulierende verbindungen | |
WO2004074244A3 (en) | Pyrimidine compounds | |
BR0311343A (pt) | Derivados de piridazina | |
NO20063196L (no) | Nye fusjonerte pyrrolokarbazoler | |
HUP0500136A2 (hu) | Oxitocin antagonista hatású szubsztituált diketo-piperazinok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
SE0200919D0 (sv) | Chemical compounds | |
WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
MXPA05007607A (es) | Inhibidores amida y ester de la metaloproteinasa de matriz. | |
WO2006079720A8 (fr) | Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants | |
HK1075663A1 (en) | Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a sb 2 /sb | |
ATE425164T1 (de) | Tetrazyklische immunmodulierende verbindungen | |
HK1061845A1 (en) | New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds | |
GB0412314D0 (en) | Compounds | |
WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
WO2004024060A3 (en) | Metalloproteinase inhibitors and intermediates for preparation thereof | |
WO2003076426A3 (en) | Pyridinyloxy derivatives as 5-ht receptor ligands | |
ATE327987T1 (de) | Methylthiophencarboxanilide | |
WO2005025492A3 (en) | Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease | |
MX2021007505A (es) | Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3. | |
WO2007009080A3 (en) | Ppar [alpha/gamma] agonists and processes of preparing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |